The Role of TPOAb in Thyroid-Associated Orbitopathy: A Systematic Review

Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1740-1746. doi: 10.1080/09273948.2021.1942498. Epub 2021 Jul 2.

Abstract

Introduction: Thyroid-associated orbitopathy (TAO) is one of the most common autoimmune inflammatory disorders of the orbit. The presence of anti-thyroid antibodies is believed to play a role in the pathogenesis and clinical status of the TAO patients. Herein, we review the usefulness of TPOAb as a biomarker for TAO.

Methods: A systematic search in MEDLINE library was conducted. Results: Twenty studies were included. TPO is expressed in orbital tissues, and the polymorphism rs11675434 SNP has proven to be associated with clinically evident TAO. Studies in pediatric patients have shown a positive correlation between high TPOAb levels and TAO. In contrast, results in adults are inconsistent. Some studies imply a protective role of TPOAb, yet the majority did not find any association. Some authors have suggested an implication of TPOAb in the pathophysiology of TAO in TRAb-negative patients.

Conclusions: The role of TPOAb in TAO remains unclear and controversial.

Keywords: TPOAb; Thyroid associated orbitopathy; anti-thyroid peroxidase antibodies; thyroid autoantibodies.

Publication types

  • Systematic Review

MeSH terms

  • Child
  • Graves Ophthalmopathy* / diagnosis
  • Graves Ophthalmopathy* / genetics
  • Humans